Previous Article | Next Article ![]()
Mol. Cell. Biol., 10 1995, 5312-5321, Vol 15, No. 10
JH Toyn, AL Johnson and LH Johnston
Saccharomyces cerevisiae dbf4 and cdc7 cell cycle mutants block initiation
of DNA synthesis (i.e., are iDS mutants) at 37 degrees C and arrest the
cell cycle with a 1C DNA content. Surprisingly, certain dbf4 and cdc7
strains divide their chromatin at 37 degrees C. We found that the
activation of the Cdc28 mitotic protein kinase and the Dbf2 kinase occurred
with the correct relative timing with respect to each other and the
observed division of the unreplicated chromatin. Furthermore, the division
of unreplicated chromatin depended on a functional spindle. Therefore, the
observed nuclear division resembled a normal mitosis, suggesting that S.
cerevisiae commits to M phase in late G1 independently of S phase. Genetic
analysis of dbf4 and cdc7 strains showed that the ability to restrain
mitosis during a late G1 block depended on the genetic background of the
strain concerned, since the dbf4 and cdc7 alleles examined showed the
expected mitotic restraint in other backgrounds. This restraint was
genetically dominant to lack of restraint, indicating that an active arrest
mechanism, or checkpoint, was involved. However, none of the previously
described mitotic checkpoint pathways were defective in the iDS strains
that carry out mitosis without replicated DNA, therefore indicating that
the checkpoint pathway that arrests mitosis in iDS mutants is novel. Thus,
spontaneous strain differences have revealed that S. cerevisiae commits
itself to mitosis in late G1 independently of entry into S phase and that a
novel checkpoint mechanism can restrain mitosis if cells are blocked in
late G1. We refer to this as the G1/M-phase checkpoint since it acts in G1
to restrain mitosis.
Copyright © 1995, American Society for Microbiology
Segregation of unreplicated chromosomes in Saccharomyces cerevisiae reveals a novel G1/M-phase checkpoint
Laboratory of Yeast Genetics, National Institute for Medical Research, Mill Hill, London, United Kingdom.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|